As of 2:34pm ET
| -0.85 / -1.06%|
The 4 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 80.50, with a high estimate of 91.00 and a low estimate of 69.00. The median estimate represents a +1.64% increase from the last price of 79.20.
The current consensus among 5 polled investment analysts is to Buy stock in Magellan Health Inc. This rating has held steady since July, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.